Global Point of Care

Alere NMP22® BladderChek®

The Alere NMP22® BladderChek® Test is a fast, easy to use and non-invasive test that aids in the diagnosis and monitoring of bladder cancer, in conjunction with standard diagnostic procedures. With results in 30 minutes at the point-of-care, results can be delivered to patients during the same office visit, allowing a rapid and cost-effective aid in the detection of bladder cancer in patients at risk.

  1. Grossman et al., JAMA Jan 18, 2006 (overall NPV: 99.8% JAMA 2006 Surveillance Study +99.3% NMP JAMA 2005 Detection Study / 2 = 99,5%)
  2. Grossman et al., JAMA Feb 16, 2005
  3. Kumar, A., Kumar R., Gupta N.  Biological Markers in the Diagnosis of Recurrent Bladder Cancer: Bladder Cancer Markers in Clinical Practice.  Jpn. J. Clin. Oncol. 2006: 36(3) 172-175.